Biora Therapeutics, Inc. Operating Cash Flow
Biora Therapeutics, Inc. reported Operating Cash Flow of -$32.18 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-11-14
- Biora Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$8.73M.
- Biora Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$10.95M.
- Biora Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$12.50M.
- Biora Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$13.74M.
- Biora Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$48.50M.
- Biora Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$64.42M.
- Biora Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$167.49M.
- Biora Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$165.74M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | -$8.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$19.68M derived: sum of 2 quarters · filed 2024-11-14 | -$32.18M 10-Q · filed 2024-11-14 | -$45.92M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2024-06-30 | -$10.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$23.45M 10-Q · filed 2024-08-12 | -$37.19M derived: sum of 3 quarters · filed 2024-08-12 | -$48.23M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2024-03-31 | -$12.50M 10-Q · filed 2024-05-15 | -$26.24M derived: sum of 2 quarters · filed 2024-05-15 | -$37.27M derived: sum of 3 quarters · filed 2024-11-14 | -$48.90M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-12-31 | -$13.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$24.78M derived: sum of 2 quarters · filed 2024-11-14 | -$36.40M derived: sum of 3 quarters · filed 2024-11-14 | -$48.50M 10-K · filed 2024-04-01 | ||
| 2023-09-30 | -$11.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$22.66M derived: sum of 2 quarters · filed 2024-11-14 | -$34.75M 10-Q · filed 2024-11-14 | -$45.77M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$11.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$23.72M 10-Q · filed 2024-08-12 | -$34.74M derived: sum of 3 quarters · filed 2024-08-12 | -$44.54M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | -$12.10M 10-Q · filed 2024-05-15 | -$23.12M derived: sum of 2 quarters · filed 2024-05-15 | -$32.92M derived: sum of 3 quarters · filed 2024-05-15 | -$52.56M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | -$11.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$20.82M derived: sum of 2 quarters · filed 2024-04-01 | -$40.46M derived: sum of 3 quarters · filed 2024-04-01 | -$64.42M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | -$9.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$29.44M derived: sum of 2 quarters · filed 2023-11-13 | -$53.40M 10-Q · filed 2023-11-13 | -$93.44M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$19.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$43.59M 10-Q · filed 2023-08-14 | -$83.64M derived: sum of 3 quarters · filed 2023-08-14 | -$126.83M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$23.95M 10-Q · filed 2023-05-15 | -$64.00M derived: sum of 2 quarters · filed 2023-05-15 | -$107.19M derived: sum of 3 quarters · filed 2023-05-15 | -$142.88M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$40.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$83.24M derived: sum of 2 quarters · filed 2023-03-30 | -$118.92M derived: sum of 3 quarters · filed 2023-03-30 | -$167.49M 10-K · filed 2023-03-30 | ||
| 2021-09-30 | -$43.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$78.88M derived: sum of 2 quarters · filed 2022-11-14 | -$127.44M 10-Q · filed 2022-11-14 | -$198.12M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$35.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$84.25M 10-Q · filed 2022-08-15 | -$154.93M derived: sum of 3 quarters · filed 2022-08-15 | -$206.79M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | -$48.56M 10-Q · filed 2022-05-10 | -$119.24M derived: sum of 2 quarters · filed 2022-05-10 | -$171.11M derived: sum of 3 quarters · filed 2022-05-10 | -$183.42M derived: sum of 4 quarters · filed 2022-05-10 | ||
| 2020-12-31 | -$70.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$122.54M derived: sum of 2 quarters · filed 2022-03-28 | -$134.86M derived: sum of 3 quarters · filed 2022-03-28 | -$165.74M 10-K · filed 2022-03-28 | ||
| 2020-09-30 | -$51.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$64.18M derived: sum of 2 quarters · filed 2021-11-10 | -$95.06M 10-Q · filed 2021-11-10 | -$95.69M 10-Q · filed 2020-11-09 | -$140.91M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$12.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$43.20M 10-Q · filed 2021-08-12 | -$44.40M 10-Q · filed 2020-08-14 | -$89.05M derived: sum of 3 quarters · filed 2021-08-12 | -$111.80M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$30.89M 10-Q · filed 2021-05-13 | -$76.73M derived: sum of 2 quarters · filed 2021-05-13 | -$99.48M derived: sum of 3 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$45.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$68.60M derived: sum of 2 quarters · filed 2021-03-18 | -$106.12M 10-K · filed 2021-03-18 | |||
| 2019-09-30 | -$22.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$60.28M 10-Q · filed 2020-11-09 | ||||
| 2019-06-30 | -$37.53M 10-Q · filed 2020-08-14 |